Positron Corporation (POSC)

[colorofmoney]

POSC NEWS..Positron Corporation (POSC), a
leading molecular imaging company specializing in the field of nuclear
cardiology, today announced it had achieved the highest mark of compliance in a
recent inspection by the Nuclear Regulatory Commission (NRC).
INDIANAPOLIS, Dec 06, 2010 (BUSINESS WIRE) --
The NRC performed a safety inspection of Positron's Indianapolis facility this
past Thursday and issued a compliance report (FORM 591M Part 1) with its
findings. The report indicated Positron achieved the highest possible compliance
notice (with no violations) available from this Federal regulatory body, which
monitors radioactive material (RAM) license holders.

"The NRC has a strong reputation for rigorousness and insistence on its standards
of procedural verification, training and documentation. A RAM license is key to
our radiopharmaceutical programs in order to conduct critical research &
development and manufacturing, now and in the future. More immediately, we will
be conducting validation testing prior to shipment of commercial products from
our Nuclear Cardio-Assist(TM) line."

"Our internal processes and controls are always driven to ensure we adhere to the
highest degree of compliance, this is further evidence of Positron's overall
commitment to excellence," stated Positron CEO Patrick G. Rooney.

The NRC periodically inspects the procedures and documentation of RAM license
holders, such as imaging centers, nuclear pharmacies and producers of radioactive
products, to ensure safe and proper handling of radioactive material. Inspections
are an examination of the activities conducted under a license issued by the NRC,
an independent Federal agency. A RAM license is required to produce and handle
radioactive pharmaceuticals. Positron received its RAM license from the NRC in
December 2009 to support its imaging device and pharmaceutical programs.

About Positron: Positron is a molecular imaging company focused on Nuclear
Cardiology. Positron utilizes its proprietary product line to provide unique
solutions to the Nuclear Medicine community ranging from imaging to
radiopharmaceutical distribution. Positron products include: the Attrius(R), a
PET imaging device; the Pulse(R), a SPECT imaging device; the Nuclear
Pharm-Assist(R), an automated radiopharmaceutical distribution device; and the
Tech-Assist (TM), a radiopharmaceutical injection shield. More information about
Positron is available at http://www.positron.com.

Forward Looking Statements: Statements in this document contain certain
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended.
These statements are based on many assumptions and estimates and are not
guarantees of future performance and may involve known and unknown risks,
uncertainties and other factors which may cause the actual results, performance
or achievements of Positron Corporation to be materially different from future
results, performance or achievements expressed or implied by such forward-looking
statements. Positron assumes no obligation to publicly update or revise these
forward-looking statements for any reason, or to update the reasons actual
results could differ materially from those anticipated in these forward-looking
staOSC NEWS..